veldoreotide [8632]
veldoreotide
| SMILES | C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCNC(=O)CCCN(CC(N)=O)C(=O)[C@H](Cc2ccccc2)NC1=O |
| InChIKey | ABFNTRQPWNXUHA-VEVJRHMJSA-N |
| Sequence | XFWWKTFG |
Chemical Properties
| Hydrogen bond acceptors | 11 |
| Hydrogen bond donors | 12 |
| Rotatable bonds | 15 |
| Log P | 1.342 |
| Molecular weight (Da) | 1122.6 |
| Stereochemistry info | partial |
Database connections
| Model (AF2) | SST4 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
veldoreotide
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
| Model (AF2) | SST4 |